Stay updated with breaking news from Neil Kumar. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
BridgeBio Pharma, Inc. (NASDAQ:BBIO – Get Rating) was the target of a significant drop in short interest in March. As of March 31st, there was short interest totalling 15,160,000 shares, a drop of 13.5% from the March 15th total of 17,520,000 shares. Currently, 13.4% of the company’s stock are short sold. Based on an average […]
Peter Brimelow writes: For various reasons, I ha...
Shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO – Get Rating) were down 5.3% on Friday . The stock traded as low as $15.52 and last traded at $15.59. Approximately 965,829 shares were traded during mid-day trading, a decline of 67% from the average daily volume of 2,905,068 shares. The stock had previously closed at $16.47. Analyst […]
Should You Buy or Sell BridgeBio Pharma Stock? Get The Latest BBIO Stock Forecast, Price Target, Earnings Estimates, Headlines, Short Interest at MarketBeat.
BridgeBio Pharma, Inc. (NASDAQ:BBIO – Get Rating)’s share price gapped up prior to trading on Wednesday . The stock had previously closed at $15.15, but opened at $16.19. BridgeBio Pharma shares last traded at $15.78, with a volume of 355,107 shares trading hands. Analysts Set New Price Targets A number of equities research analysts have […]